CU Anschutz Cancer Center's Christine Conageski, MD, MSc, says gynecologists should be trained to screen for anal cancer, which is rising in incidence in older women: https://bit.ly/4vRSlX6

The work of James Costello, PhD, and a multidisciplinary science team is backed by a two-year ASPIRE grant from the CU Anschutz Cancer Center and @cumedicalschool.bsky.social: https://bit.ly/3Qw8CSv

Sarcoma Awareness Month: Masanori Hayashi, MD, shared the latest on his research into BCOR-CCNB3 sarcomas (BCS), a subtype of small cell sarcomas: https://bit.ly/4oUtrnn

Ajay Major (@majorajay.bsky.social), MD, MBA, is the lead author of a new study that evaluates the time burdens that cancer therapies impose on patients in connection with new therapies for both slow-growing and aggressive lymphomas: https://bit.ly/3SkYAEj

At last week's Research Roadshow, participants spoke with CU Anschutz Cancer Center leaders, members, and staff about cancer prevention, new treatments, research, and clinical trials. Learn more about Research Roadshows: https://bit.ly/3SzyP33

When cancer metastasizes, it increases the risk of mortality. To fight this, CU Anschutz Cancer Center leader Heide Ford, PhD, and her lab are studying how cancer metastasizes in the first place. Learn more about this research and Ford's career: https://bit.ly/43Ug3Wn

Kayla Calkin rides waves of emotions after an invasive ductal breast cancer diagnosis at 36 while trying to start a family: https://bit.ly/4oH2TWu

Challenging the standard of care for melanoma brain metastases, CU Anschutz neurosurgeon Robert Breeze, MD, pursued aggressive treatment options that are now commonplace. Learn about how treatment has changed and the melanoma clinical trials offered here at the Cancer Center: https://bit.ly/4f1CAa9

CU Anschutz Cancer Center's Theresa Pacheco, MD, says bemotrizinol, a newly FDA-approved chemical filter that blocks the sun’s rays, offers protection against both damaging UVA and UVB light ⬇️ https://bit.ly/4ouiubG

CU Anschutz Cancer Center member and radiation oncologist Brian Kavanagh, MD, MPH, talks about radiation therapy treatment, its side effects, and recent advances: https://bit.ly/4uAb4Ff

After five years of reviewing and understanding how work affects cancer treatment, the WeCanWork program is now equipping clinicians to support patients who keep working through cancer: https://bit.ly/44cqaGe

At the @ascocancer.bsky.social Annual Meeting, Manali Kamdar, MD, shared long-term safety data on liso-cel, which demonstrated sustained tolerability, support for outpatient care, and increased patient access ⬇️ https://news.cuanschutz.edu/cancer-center/car-t-therapy-asco-2026-findings

The U.S. News & World Report has released its 2026-2027 Best Global Universities rankings. We're proud of our oncologists for their tireless efforts in the fight against cancer. This ranking of the @cuanschutz.bsky.social reflects their work: https://bit.ly/3QLegA3

One of the biggest lessons Michael Verneris, MD, has learned as a leader is to lead by example and keep patients at the center of every decision. Watch the full interview: www.youtube.com/watch?v=kd2H...

Associate Director for Clinical Research, Christopher Lieu, MD, shares how a new drug called daraxonrasib offers a critical advance in treating metastatic pancreatic cancer ⬇️ https://bit.ly/4efMpkJ

In this Q&A, CU Anschutz Cancer Center member and Assistant Professor of Urology at @cudeptsurg.bsky.social, Jeff Morrison, MD, shares how both cancer and treatments such as chemotherapy, surgery, and radiation affect male fertility: https://bit.ly/3Q02XDX

Carlo Caballero, LPC, CCM, of the Office of Community Outreach and Engagement, has been named in the seventh annual Cancer Health 25 feature dedicated to financial helpers and fundraisers: https://bit.ly/4vASihS

Trained as a biologist, Diana Cittelly, PhD, began her research journey in Colombia before moving to the U.S. Her work focuses on translational breast cancer research, studying metastasis to improve real-world patient outcomes. Watch the full interview here: youtu.be/ttGsG6o7oX0?...

We have two new endowed chairs: the Dudley Family Endowed Chair in Cancer Excellence, with Jon Vogel, MD, serving as the chairholder; and the Dudley Family Rising Star Endowed Chair, with Michael Oliphant, PhD, named as the inaugural chairholder! Thank you to the Dudley family!

CU Anschutz Cancer Center's acute myeloid leukemia researchers say that a key to research success is the spirit of collaboration that flourishes across @cuanschutz.bsky.social. Read the cover story of the Spring 2026 issue of the C3: https://bit.ly/4vC1iDB

CU Anschutz Cancer Center leader Heide Ford, PhD, is researching ways to target the “programs” the cancer cells use to change their state. Read about Ford's work: https://bit.ly/43Ug3Wn

It's #NationalCancerSurvivorsDay. In this article, Jennifer Diamond, MD, discusses the roles of both clinical trial researchers and participants and how they affect the rise in cancer survivorship: https://news.cuanschutz.edu/cancer-center/clinical-trials-increase-cancer-survivorship

#NationalCancerSurvivorsDay: Honoring survivors, inspiring the future. In honor of this day, we've gathered patient stories from over the last year to show that survivorship is not a single milestone but an ongoing, evolving experience: https://news.cuanschutz.edu/cancer-center/survivors-day-2026

Norm Taylor established an endowed chair, named for his late wife, Katie, to advance and support uterine cancer research at the CU Anschutz Cancer Center: https://bit.ly/43LpDL9

Uterine Cancer Awareness Month: There are around 68,000 new cases of this disease in the U.S. every year. This number is rising and has made uterine cancer the fourth most common cancer among women. Christine Walsh, MD, MS, shares why ⬇️ https://bit.ly/4vs6muj

CU Anschutz Cancer Center leader Curtis Henry, PhD, and postdoctoral fellow Claire Pillsbury, PhD, are looking at the medications’ effects on cancer and autoimmune disease ⬇️ https://news.cuanschutz.edu/cancer-center/glp1-drugs-boost-immunity

In our latest Q&A, CU Anschutz Cancer Center's Jill Alldredge, MD, helps us better understand premature menopause and fertility issues induced by cancer treatments ⬇️ https://news.cuanschutz.edu/cancer-center/alldredge-chemopause-premature-menopause-oncofertility

In this Q&A, CU Anschutz Cancer Center's Rajeev Vibhakar, MD, PhD, talks about his dual role as a clinician and researcher of pediatric brain tumors: https://bit.ly/3QdiakZ

The @americancancersoc.bsky.social has updated its colorectal cancer screening guidelines. CU Anschutz Cancer Center's Swati Patel, MD, and Andi Dwyer, MPH, share their insights on the changes and what it means for Coloradans: https://bit.ly/4u8Bv4B

Results from a clinical trial of a CAR T-cell treatment for brain tumors that naturally occur in dogs could eventually lead to a similar clinical trial for pediatric high-grade gliomas: https://bit.ly/3PPcuxh

The annual Thoracic Oncology Research Initiative (TORI) Lung Cancer SPORE Retreat was held yesterday, where attendees shared their research milestones and updates on ongoing projects and brainstormed future collaborations. Learn more about TORI: https://bit.ly/3PIIYcM

Led locally by CU Anschutz Cancer Center's Marie Wood, MD, EvoPAR, a worldwide clinical trial, is investigating a pair of new therapies for advanced breast cancer: https://bit.ly/4nTAEU6

Colorado School of Mines senior David Boylan, who was recently diagnosed with leukemia, graduated in the halls of the oncology ward at our clinical partner UCHealth in a surprise ceremony put together by his care team: https://cbsn.ws/4wJmU2h

Glioblastoma is the most common and most aggressive malignant brain tumor in adults, with most frequently diagnosed at ages 45–70. For Brain Cancer Awareness Month, learn more about glioblastoma: https://bit.ly/49W4xNB

#ClinicalTrialsDay: CU Anschutz Cancer Center's Jennifer Diamond, MD, shares why patients consider clinical trials. Explore our latest clinical trials and more: https://bit.ly/4dUgrdf

To better understand your risk of cancer, it helps to know your family health history. Learn more from CU Anschutz Cancer Center experts: https://news.cuanschutz.edu/cancer-center/ku-lowery-family-cancer-history

Watch McKenna Russen, a GI clinical research coordinator in the CU Anschutz Cancer Center's Cancer Clinical Trials Office (CCTO), share a day in her life. Learn more about the CCTO: https://medschool.cuanschutz.edu/colorado-cancer-center/clinical-trials/clinical-research/ccto-team

CU Anschutz Cancer Center's Saketh Guntupalli, MD, was named the 2026 Champion of Hope Award winner at this year's Cancer League of Colorado's Hope Ball! The CU Anschutz Cancer Center is a proud sponsor of this event.

With @fightcrc.bsky.social, Andi Dwyer, MPH, and Swati G. Patel, MD, helped lead an initiative to ensure that Lynch syndrome is included in International Classification of Diseases (ICD-10) codes: https://bit.ly/4u8VWiZ

You may have heard of CAR T-cell therapy, but now there's an effort by Siddhartha Mitra, PhD, and his team to develop CAR M. The goal? To re-engineer marcophages instead of T cells, to "eat" cancer cells: https://bit.ly/3RjG52h

Former NBA player Jason Collins passed away this week after a battle with Stage 4 glioblastoma, a rare form of brain cancer. In this Q&A, CU Anschutz Cancer Center member Douglas Ney, MD, talks about glioblastoma and its rising prevalence in younger patients ⬇️ https://bit.ly/497RCIy

CU Anschutz Cancer Center's Tejas Patil, MD, and Peter Fecci, MD, PhD, are joining forces to investigate a new way to treat leptomeningeal disease stemming from a form of lung cancer: https://news.cuanschutz.edu/cancer-center/patil-fecci-leptomeningeal-disease

Leading with intention and self-awareness, Diana Cittelly, PhD, creates a collaborative space that values transparency, growth, and diverse working styles. See the full interview here: youtu.be/ttGsG6o7oX0?...

Congrats to CU Anschutz Cancer Center's Curtis Henry, PhD, on being named the American Association of Immunologists (@aai.org) Vanguard Award winner in recognition of his research achievement and exemplary career success: https://news.aai.org/2026/05/06/curtis-j-henry-receives-aai-vanguard-award/

Some cancer drugs disrupt taste by changing the cells inside taste buds, CU Anschutz Cancer Center-led research shows: https://bit.ly/4d1gcNr

Brain Cancer Awareness Month: CU Anschutz Cancer Center's Peter Fecci, MD, PhD, shares the origins of cancer in the brain and how different types are treated: https://bit.ly/4tTxhyF

How does chemotherapy work, and what are some of its side effects? CU Anschutz Cancer Center member Jenny Xiang, MD, answers these questions: https://bit.ly/4ut69Gz

Cancer center members Joanna Arch, PhD, and Jean Kutner, MD, MSPH, created an intervention for advanced cancer patients to help them with anxiety, depression, and advance care planning: https://bit.ly/41OVKZI

The best way to treat pancreatic cancer? Stop it from developing in the first place. That’s the thrust of a presentation delivered by CU Anschutz Cancer Center leader Hatim Sabaawy, MD, PhD, at the Rocky Mountain Pancreatic Cancer Symposium: https://bit.ly/4ueYc7U

Daraxonrasib is trending — here’s what to know 👀 “This could be a game changer for pancreatic cancer,” says Christopher Lieu, MD. (@cucancercenter.bsky.social) As the FDA fast-tracks its review, early data is giving new hope in a disease with limited options. Read more: https://bit.ly/4rU8wRn